Delivery Order SPE2DB25D3017-SPE2DB26FVGUK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in a 28-day supply package. This is a firm fixed-price delivery order with a ceiling value of $1,384.70, representing a non-set-aside competitive award. The contract is set to be completed by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in 28-count packaging, with a ceiling value of $2,225.65. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,575.17 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count package) under a firm fixed-price contract with a ceiling value of $3,926.40. This is a non-set-aside, competitively awarded delivery order representing a single pharmaceutical product delivery. The contract is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGUKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages) with a ceiling value of $11,152.11. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 prime IDC with DLA Troop Support Medical (designated SPE2DX, running through December 2026), which serves as a global pharmaceutical support vehicle supplying medications and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen routinely fulfills delivery orders for brand-name and generic pharmaceuticals across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 10/28/25 |